study to find out the efficacy of 0.75% ropivacaine alone or with dexmedetomidine in upper limb suregries.
Phase 3
- Conditions
- Health Condition 1: M859- Disorder of bone density and structure, unspecified
- Registration Number
- CTRI/2023/10/059111
- Lead Sponsor
- Department of Anesthesia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
120 patients of either sex, aged 18—60 years, belonging to American Society of Anesthesiologists (ASA) physical status class I and Il presenting for upper limb elective surgery under supraclavicular block.
Exclusion Criteria
Who refuse to give consent.
With severe cardiac, renal, endocrine, pulmonary disease.
In physical status ASA grade Ill or higher.
Who are allergic to trial drugs.
Who are having local site infection.
With hemi-diaphragmatic paralysis on opposite side of surgery
With any psychological disorder who would interfere with assessment of pain.
With history of brachial plexus injury.
With bilateral upper limb surgery and fracture.
With heart rate already on the lower side i.e 55 or less than 55b/m.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine whether the efficacy of 0.75% Ropivacaine with <br/ ><br>dexmedetomidine is greater than 0.75% Ropivacaine used alone in supraclavicular brachial plexus block for upper limb surgeries. <br/ ><br>Timepoint: Onset & duration of Sensory block. Onset and duration of motor block. Duration of analgesia. <br/ ><br>
- Secondary Outcome Measures
Name Time Method To compare the Hemodynamic parameters Complications. <br/ ><br>Timepoint: To compare the Hemodynamic parameters Complications. <br/ ><br>